Bristol Myers Squibb (BMY) Insider Trading & Ownership $46.35 0.00 (0.00%) As of 06/30/2025 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Bristol Myers Squibb (NYSE:BMY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.07%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$402.23KNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$42.62K Get BMY Insider Trade Alerts Want to know when executives and insiders are buying or selling Bristol Myers Squibb stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMY Insider Buying and Selling by Quarter Bristol Myers Squibb Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/9/2025Benjamin HickeyInsiderSell97$38.01$3,686.97 4/25/2025Samit HirawatEVPBuy4,250$47.58$202,215.00 4/15/2025Tommy TubervilleU.S. Congress Member (R-AL)Sell$49.98$1,001 - $15,0004/1/2025Julie JohnsonU.S. Congress Member (D-TX)Sell$59.53$1,001 - $15,0003/27/2025Greg LandsmanU.S. Congress Member (D-OH)Sell$58.90$1,001 - $15,0002/14/2025Samit HirawatEVPBuy1,823$54.84$99,973.32 1/15/2025Julie JohnsonU.S. Congress Member (D-TX)Buy$55.96$1,001 - $15,00012/6/2024Virginia FoxxU.S. Congress Member (R-NC)Buy$59.38$1,001 - $15,00011/4/2024Phil M HolzerSVPSell700$55.62$38,934.00 11/1/2024Samit HirawatEVPBuy1,830$54.67$100,046.10 (Data available from 1/1/2013 forward) BMY Insider Trading Activity - Frequently Asked Questions Who is on Bristol Myers Squibb's Insider Roster? The list of insiders at Bristol Myers Squibb includes Ann Powell, Benjamin Hickey, Christopher S Boerner, David V Elkins, Giovanni Caforio, Phil M Holzer, Robert M Plenge, Rupert Vessey, Samit Hirawat, and Theodore R Samuels II. Learn more on insiders at BMY. What percentage of Bristol Myers Squibb stock is owned by insiders? 0.07% of Bristol Myers Squibb stock is owned by insiders. Learn more on BMY's insider holdings. Which Bristol Myers Squibb insiders have been buying company stock? The following insiders have purchased BMY shares in the last 24 months: Christopher S Boerner ($249,609.06), Samit Hirawat ($402,234.42), and Theodore R Samuels II ($423,385.00). How much insider buying is happening at Bristol Myers Squibb? Insiders have purchased a total of 21,474 BMY shares in the last 24 months for a total of $1,075,228.48 bought. Which Bristol Myers Squibb insiders have been selling company stock? The following insiders have sold BMY shares in the last 24 months: Ann Powell ($1,101,642.50), Benjamin Hickey ($3,686.97), Phil M Holzer ($38,934.00), and Robert M Plenge ($44,754.48). How much insider selling is happening at Bristol Myers Squibb? Insiders have sold a total of 19,515 Bristol Myers Squibb shares in the last 24 months for a total of $1,189,017.95 sold. Which members of congress are trading Bristol Myers Squibb? Julie Johnson (D-TX) and Virginia Foxx (R-NC) have bought shares of Bristol Myers Squibb in the last year totaling $16,000. Tommy Tuberville (R-AL), Julie Johnson (D-TX), and Greg Landsman (D-OH) have sold shares totaling $24,000. Bristol Myers Squibb Key ExecutivesDr. Christopher S. Boerner Ph.D. (Age 53)CEO & Chairman Compensation: $3.14MMr. David V. Elkins (Age 56)Executive VP & CFO Compensation: $2.28MMs. Sandra Leung Esq. (Age 63)Executive VP & General Counsel Compensation: $2.58MMr. Samit Hirawat M.D. (Age 55)Executive VP, Chief Medical Officer & Head of Development Compensation: $2.62M2 recent tradesMr. Greg Meyers (Age 51)Executive VP and Chief Digital & Technology Officer Mr. Timothy PowerVP & Head of Investor RelationsMs. Kimberly M. JablonskiChief Compliance & Ethics OfficerMs. Ahn Amanda Poole (Age 49)Executive Vice President & Chief Human Resources Officer Dr. Joseph J. Eiden Jr. (Age 75)Head of Medical Affairs Mr. Adam Lenkowsky (Age 52)Executive VP, Chief Commercialization Officer & Head of U.S. Oncology More Insider Trading Tools from MarketBeat Related Companies Johnson & Johnson Insider Buying AbbVie Insider Buying Merck & Co., Inc. Insider Buying Pfizer Insider Buying Zoetis Insider Buying Royalty Pharma Insider Buying Corcept Therapeutics Insider Buying Jazz Pharmaceuticals Insider Buying Perrigo Insider Buying Supernus Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support This page (NYSE:BMY) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol Myers Squibb Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
